Gwenaëlle Gravis Selected Research

Tyrosine Kinase Inhibitors

1/2022	Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
1/2019	Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.
2/2012	Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gwenaëlle Gravis Research Topics

Disease

16	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2004
11	Neoplasms (Cancer) 01/2022 - 11/2006
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 07/2011
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 12/2014
4	Carcinoma (Carcinomatosis) 11/2018 - 11/2006
3	Neutropenia 01/2022 - 10/2010
3	Fatigue 01/2022 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2015
2	Febrile Neutropenia 01/2022 - 10/2010
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
1	Massive Hepatic Necrosis 01/2022
1	Heart Failure 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Digestive System Diseases 01/2022
1	Seminoma 01/2022
1	Liver Failure 01/2022
1	Vitiligo 01/2019
1	Vomiting 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Nausea 01/2017
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2016
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Testicular Neoplasms (Testicular Cancer) 12/2014
1	Nonseminomatous germ cell tumor 12/2014
1	Edema (Dropsy) 01/2013
1	Esophagitis 03/2012
1	Hemorrhage 03/2012
1	Constipation 01/2011
1	Kidney Neoplasms (Kidney Cancer) 01/2011
1	Hypothyroidism 01/2011
1	Asthenia 01/2011

Drug/Important Bio-Agent (IBA)

10	Docetaxel (Taxotere)FDA Link 01/2022 - 06/2009
7	AndrogensIBA 01/2022 - 11/2006
4	NivolumabIBA 01/2022 - 01/2019
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 10/2010
3	Sunitinib (Sutent)FDA Link 01/2022 - 07/2011
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2017
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2012
3	IpilimumabIBA 01/2022 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2016
3	Hormones (Hormone)IBA 10/2021 - 10/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2010
3	PlatinumIBA 11/2018 - 01/2015
3	Gemcitabine FDA Link 01/2017 - 01/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
2	Axitinib (AG 013736)IBA 01/2020 - 10/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 07/2011
2	Immune Checkpoint InhibitorsIBA 01/2019 - 11/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2016 - 07/2015
2	Estramustine FDA Link 07/2015 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2006
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2013 - 10/2010
2	taxaneIBA 07/2012 - 10/2010
2	cabazitaxel FDA Link 07/2012 - 10/2010
1	abirateroneIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	cabozantinibIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2018
1	atezolizumabIBA 01/2018
1	vinflunineIBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	Alkaline PhosphataseIBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2016
1	Abiraterone AcetateIBA 04/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	SaltsIBA 01/2015
1	Fetal Proteins (Fetoprotein)IBA 12/2014
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 12/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2013
1	rilotumumabIBA 01/2013
1	Biological ProductsIBA 01/2013
1	Monoclonal AntibodiesIBA 01/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2012
1	CoagulantsIBA 03/2012
1	Interferon-alpha (Interferon Alfa)IBA 07/2011
1	Bevacizumab (Avastin)FDA Link 07/2011
1	temsirolimus FDA Link 07/2011
1	Thyroid HormonesIBA 01/2011
1	TubulinIBA 10/2010
1	DNA (Deoxyribonucleic Acid)IBA 11/2006

Therapy/Procedure

13	Therapeutics 01/2022 - 10/2010
10	Drug Therapy (Chemotherapy) 01/2022 - 06/2009
9	Castration 01/2022 - 06/2009
3	Immunotherapy 01/2019 - 06/2015
2	Lymph Node Excision (Lymph Node Dissection) 12/2014 - 01/2012
1	Radiotherapy 01/2022
1	Investigational Therapies (Experimental Therapy) 10/2021
1	JET protocol 01/2021
1	Nephrectomy 01/2019
1	Cryosurgery 01/2019
1	Duration of Therapy 04/2015
1	Aftercare (After-Treatment) 10/2010
1	Prostatectomy (Retropubic Prostatectomy) 11/2006